Glibenclamide mini-tablets with an enhanced pharmacokinetic and pharmacodynamic performance
first_published_at:Oct. 1, 2018, midnight / date_published:Oct. 1, 2018
Papers
-
01/10/2018 -
by
Hesham M. Tawfeek,
Matthew Roberts,
Mohamed A. El Hamd,
Ahmed A. H. Abdellatif,
Mahmoud A. Younis
In an effort to reduce the dosage, anticipated side effects, and production costs of glibenclamide (GLC), a potent oral hypoglycemic drug, the study aimed to enhance dissolution and, consequently, oral …
